ID   KKCC1_HUMAN             Reviewed;         505 AA.
AC   Q8N5S9; Q9BQH3;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 2.
DT   12-OCT-2022, entry version 174.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase kinase 1;
DE            Short=CaM-KK 1;
DE            Short=CaM-kinase kinase 1;
DE            Short=CaMKK 1;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM-kinase IV kinase;
DE   AltName: Full=Calcium/calmodulin-dependent protein kinase kinase alpha;
DE            Short=CaM-KK alpha;
DE            Short=CaM-kinase kinase alpha;
DE            Short=CaMKK alpha;
GN   Name=CAMKK1; Synonyms=CAMKKA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Harvey M., Carra S., Tascedda F., Barden N.;
RT   "Characterization of human CaMKK alpha gene structure.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   GLY-375.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF CAMK1D.
RX   PubMed=12935886; DOI=10.1016/s0014-5793(03)00817-2;
RA   Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,
RA   Kobayashi R.;
RT   "Identification and characterization of novel components of a
RT   Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.";
RL   FEBS Lett. 550:57-63(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67 AND SER-458, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] GLY-375.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that belongs to a
CC       proposed calcium-triggered signaling cascade involved in a number of
CC       cellular processes. Phosphorylates CAMK1, CAMK1D, CAMK1G and CAMK4.
CC       Involved in regulating cell apoptosis. Promotes cell survival by
CC       phosphorylating AKT1/PKB that inhibits pro-apoptotic BAD/Bcl2-
CC       antagonist of cell death. {ECO:0000269|PubMed:12935886}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may relieve intrasteric autoinhibition. Partially inhibited
CC       upon phosphorylation by PRCAKA/PKA (By similarity). May be regulated
CC       through phosphorylation by CAMK1 and CAMK4. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CAMK4 and calmodulin. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8N5S9; Q04917: YWHAH; NbExp=6; IntAct=EBI-6424030, EBI-306940;
CC       Q8N5S9-2; P21333-2: FLNA; NbExp=3; IntAct=EBI-25850646, EBI-9641086;
CC       Q8N5S9-2; P04792: HSPB1; NbExp=3; IntAct=EBI-25850646, EBI-352682;
CC       Q8N5S9-2; P42858: HTT; NbExp=9; IntAct=EBI-25850646, EBI-466029;
CC       Q8N5S9-2; O60333-2: KIF1B; NbExp=3; IntAct=EBI-25850646, EBI-10975473;
CC       Q8N5S9-2; P07196: NEFL; NbExp=3; IntAct=EBI-25850646, EBI-475646;
CC       Q8N5S9-2; Q99497: PARK7; NbExp=3; IntAct=EBI-25850646, EBI-1164361;
CC       Q8N5S9-2; Q8N2W9: PIAS4; NbExp=3; IntAct=EBI-25850646, EBI-473160;
CC       Q8N5S9-2; P60891: PRPS1; NbExp=3; IntAct=EBI-25850646, EBI-749195;
CC       Q8N5S9-2; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-25850646, EBI-396669;
CC       Q8N5S9-2; P37840: SNCA; NbExp=3; IntAct=EBI-25850646, EBI-985879;
CC       Q8N5S9-2; P00441: SOD1; NbExp=3; IntAct=EBI-25850646, EBI-990792;
CC       Q8N5S9-2; O76024: WFS1; NbExp=3; IntAct=EBI-25850646, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=A, Variant 3;
CC         IsoId=Q8N5S9-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, Variant 1;
CC         IsoId=Q8N5S9-2; Sequence=VSP_012140, VSP_012141;
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin binding
CC       region and may be involved in intrasteric autoinhibition.
CC   -!- DOMAIN: The RP domain (arginine/proline-rich) is involved in the
CC       recognition of CAMKI and CAMK4 as substrates. {ECO:0000250}.
CC   -!- PTM: Appears to be autophosphorylated in a Ca(2+)/calmodulin-dependent
CC       manner. Phosphorylated at multiple sites by PRCAKA/PKA. Phosphorylation
CC       of Ser-458 is blocked upon binding to Ca(2+)/calmodulin. In vitro,
CC       phosphorylated by CAMK1 and CAMK4 (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF425232; AAN37386.1; -; mRNA.
DR   EMBL; AF425301; AAN37387.1; -; mRNA.
DR   EMBL; AL136576; CAB66511.1; -; mRNA.
DR   EMBL; BC031647; AAH31647.1; -; mRNA.
DR   EMBL; BC043487; AAH43487.1; -; mRNA.
DR   CCDS; CCDS11038.1; -. [Q8N5S9-1]
DR   CCDS; CCDS11039.1; -. [Q8N5S9-2]
DR   RefSeq; NP_115670.1; NM_032294.2. [Q8N5S9-1]
DR   RefSeq; NP_757343.2; NM_172206.1.
DR   RefSeq; NP_757344.2; NM_172207.2. [Q8N5S9-2]
DR   RefSeq; XP_016880709.1; XM_017025220.1. [Q8N5S9-1]
DR   PDB; 6CCF; X-ray; 2.10 A; A/B=124-411.
DR   PDB; 6CD6; X-ray; 2.20 A; A/B/C/D=124-411.
DR   PDBsum; 6CCF; -.
DR   PDBsum; 6CD6; -.
DR   AlphaFoldDB; Q8N5S9; -.
DR   SMR; Q8N5S9; -.
DR   BioGRID; 123981; 34.
DR   IntAct; Q8N5S9; 43.
DR   MINT; Q8N5S9; -.
DR   STRING; 9606.ENSP00000158166; -.
DR   BindingDB; Q8N5S9; -.
DR   ChEMBL; CHEMBL5256; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q8N5S9; -.
DR   GuidetoPHARMACOLOGY; 1956; -.
DR   GlyGen; Q8N5S9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8N5S9; -.
DR   PhosphoSitePlus; Q8N5S9; -.
DR   BioMuta; CAMKK1; -.
DR   DMDM; 56404620; -.
DR   EPD; Q8N5S9; -.
DR   jPOST; Q8N5S9; -.
DR   MassIVE; Q8N5S9; -.
DR   MaxQB; Q8N5S9; -.
DR   PeptideAtlas; Q8N5S9; -.
DR   PRIDE; Q8N5S9; -.
DR   ProteomicsDB; 72092; -. [Q8N5S9-1]
DR   ProteomicsDB; 72093; -. [Q8N5S9-2]
DR   TopDownProteomics; Q8N5S9-2; -. [Q8N5S9-2]
DR   Antibodypedia; 3968; 215 antibodies from 32 providers.
DR   DNASU; 84254; -.
DR   Ensembl; ENST00000158166.5; ENSP00000158166.5; ENSG00000004660.15. [Q8N5S9-2]
DR   Ensembl; ENST00000348335.7; ENSP00000323118.3; ENSG00000004660.15. [Q8N5S9-1]
DR   GeneID; 84254; -.
DR   KEGG; hsa:84254; -.
DR   MANE-Select; ENST00000348335.7; ENSP00000323118.3; NM_032294.3; NP_115670.1.
DR   UCSC; uc002fwu.4; human. [Q8N5S9-1]
DR   CTD; 84254; -.
DR   DisGeNET; 84254; -.
DR   GeneCards; CAMKK1; -.
DR   HGNC; HGNC:1469; CAMKK1.
DR   HPA; ENSG00000004660; Tissue enhanced (brain).
DR   MIM; 611411; gene.
DR   neXtProt; NX_Q8N5S9; -.
DR   OpenTargets; ENSG00000004660; -.
DR   PharmGKB; PA26051; -.
DR   VEuPathDB; HostDB:ENSG00000004660; -.
DR   eggNOG; KOG0585; Eukaryota.
DR   GeneTree; ENSGT00940000154890; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q8N5S9; -.
DR   OMA; MACGPCM; -.
DR   OrthoDB; 1044255at2759; -.
DR   PhylomeDB; Q8N5S9; -.
DR   TreeFam; TF313013; -.
DR   PathwayCommons; Q8N5S9; -.
DR   Reactome; R-HSA-111932; CaMK IV-mediated phosphorylation of CREB.
DR   Reactome; R-HSA-442729; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde.
DR   Reactome; R-HSA-9619229; Activation of RAC1 downstream of NMDARs.
DR   SignaLink; Q8N5S9; -.
DR   SIGNOR; Q8N5S9; -.
DR   BioGRID-ORCS; 84254; 16 hits in 1112 CRISPR screens.
DR   ChiTaRS; CAMKK1; human.
DR   GeneWiki; CAMKK1; -.
DR   GenomeRNAi; 84254; -.
DR   Pharos; Q8N5S9; Tchem.
DR   PRO; PR:Q8N5S9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q8N5S9; protein.
DR   Bgee; ENSG00000004660; Expressed in right frontal lobe and 143 other tissues.
DR   ExpressionAtlas; Q8N5S9; baseline and differential.
DR   Genevisible; Q8N5S9; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Cytoplasm; Kinase; Methylation; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..505
FT                   /note="Calcium/calmodulin-dependent protein kinase kinase
FT                   1"
FT                   /id="PRO_0000086141"
FT   DOMAIN          128..409
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          26..61
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          167..189
FT                   /note="RP domain"
FT   REGION          435..440
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          438..463
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          460..505
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        275
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         134..142
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         157
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         78
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VBY2"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P97756"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97756"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         228
FT                   /note="L -> LALQNQAQNIQLDSTNIAKPHSLLPSEQQDSGSTWAARS (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_012140"
FT   VAR_SEQ         483..505
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11230166,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_012141"
FT   VARIANT         375
FT                   /note="E -> G (in dbSNP:rs7214723)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_020531"
FT   STRAND          128..136
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          138..147
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   TURN            148..151
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          152..160
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   TURN            161..163
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           195..205
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          214..219
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          223..231
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           249..268
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           314..316
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           319..322
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           331..348
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           358..367
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   STRAND          374..376
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           380..389
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           400..405
FT                   /evidence="ECO:0007829|PDB:6CCF"
FT   HELIX           407..410
FT                   /evidence="ECO:0007829|PDB:6CCF"
SQ   SEQUENCE   505 AA;  55735 MW;  92A055D20E487C86 CRC64;
     MEGGPAVCCQ DPRAELVERV AAIDVTHLEE ADGGPEPTRN GVDPPPRARA ASVIPGSTSR
     LLPARPSLSA RKLSLQERPA GSYLEAQAGP YATGPASHIS PRAWRRPTIE SHHVAISDAE
     DCVQLNQYKL QSEIGKGAYG VVRLAYNESE DRHYAMKVLS KKKLLKQYGF PRRPPPRGSQ
     AAQGGPAKQL LPLERVYQEI AILKKLDHVN VVKLIEVLDD PAEDNLYLVF DLLRKGPVME
     VPCDKPFSEE QARLYLRDVI LGLEYLHCQK IVHRDIKPSN LLLGDDGHVK IADFGVSNQF
     EGNDAQLSST AGTPAFMAPE AISDSGQSFS GKALDVWATG VTLYCFVYGK CPFIDDFILA
     LHRKIKNEPV VFPEEPEISE ELKDLILKML DKNPETRIGV PDIKLHPWVT KNGEEPLPSE
     EEHCSVVEVT EEEVKNSVRL IPSWTTVILV KSMLRKRSFG NPFEPQARRE ERSMSAPGNL
     LVKEGFGEGG KSPELPGVQE DEAAS
//
